id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2011-D-0799-0001,FDA,FDA-2011-D-0799,"Draft Guidance for Industry: Use of Nucleic Acid Tests on Pooled and
Individual Samples From Donors of Whole Blood and Blood Components,
Including Source Plasma, to Reduce the Risk of Transmission of Hepatitis
B Virus",Notice,Notice of Availability,2011-11-28T05:00:00Z,2011,11,2011-11-28T05:00:00Z,2012-01-28T04:59:59Z,2015-04-03T22:40:47Z,2011-30449,0,0,0900006480f74467
FDA-2011-D-0799-0002,FDA,FDA-2011-D-0799,"Draft Guidance for Industry: Use of Nucleic Acid Tests on Pooled and Individual Samples from Donors of Whole Blood and Blood Components, including Source Plasma, to Reduce the Risk of Transmission of Hepatitis B Virus",Other,Guidance,2011-11-28T05:00:00Z,2011,11,2011-11-28T05:00:00Z,,2011-11-28T15:18:52Z,,0,0,0900006480f74938